Literature DB >> 25747119

Modern surgical management of breast cancer therapy related upper limb and breast lymphoedema.

Nelson Leung1, Dominic Furniss2, Henk Giele3.   

Abstract

Breast cancer is the commonest cancer in the UK. Advances in breast cancer treatment means that the sequelae of treatment are affecting more women and for a longer duration. Lymphoedema is one such sequela, with wide-ranging implications, from serious functional and psychological effects at the individual level to wider economic burdens to society. Breast cancer-related lymphoedema is principally managed by conservative therapy comprising compression garments and manual decongestive massage. This approach is effective for early stages of lymphoedema, but it is not curative and the effectiveness depends on patient compliance. Early surgical approaches were ablative, gave significant morbidity and hence, reserved for the most severe cases of refractory lymphoedema. However, recent non-ablative reconstructive surgical approaches have seen a revival of interest in the prevention or surgical management of breast cancer-related lymphoedema. This review examines the modern surgical techniques for the treatment of breast cancer-related lymphoedema. Liposuction reduces the volume and symptoms of lymphedema, but requires continual compressive therapy to avoid recurrence. Lymphatic reconstruction or bypass techniques including lymph node transfer (inguinal nodes are transferred to the affected limb), lymphatico-lymphatic bypass (lymphatics bypass the axilla using a lymph vessel graft reconstructing lymphatic flow from arm to neck) and lymphaticovenous anastomoses (lymphatics in the arm are joined to the venous system aiding lymph drainage) show promise in reducing lymphedema significantly. Further research is required, including into the role of primary lymphaticovenous anastomoses in the prevention of lymphedema at the time of axillary dissection.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer related-lymphoedema; Liposuction; Lymph node transfer; Lymphatico-lymphatic bypass; Lymphaticovenous anastomoses; Lymphoedema

Mesh:

Year:  2015        PMID: 25747119     DOI: 10.1016/j.maturitas.2015.01.012

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  6 in total

Review 1.  The Lymphatic System in Disease Processes and Cancer Progression.

Authors:  Timothy P Padera; Eelco F J Meijer; Lance L Munn
Journal:  Annu Rev Biomed Eng       Date:  2016-02-05       Impact factor: 9.590

2.  Vascularized Lymph Node Transfer Improved Outcomes of Elderly Patients with Secondary Upper Extremity Lymphedema.

Authors:  Eamon C Francis; Bong-Sung Kim; Miffy Chia-Yu Lin; Ming-Huei Cheng
Journal:  Ann Surg Oncol       Date:  2022-07-02       Impact factor: 4.339

3.  Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment.

Authors:  Silja P Markkula; Nelson Leung; Victoria B Allen; Dominic Furniss
Journal:  Cochrane Database Syst Rev       Date:  2019-02-19

4.  Current Treatments for Breast Cancer-Related Lymphoedema: A Systematic Review

Authors:  Lun Li; Liqin Yuan; Xianyu Chen; Quan Wang; Jinhui Tian; Kehu Yang; Enxiang Zhou
Journal:  Asian Pac J Cancer Prev       Date:  2016-11-01

5.  Lymphaticovenous anastomosis (LVA) for breast cancer-related lymphedema treatment.

Authors:  Mario F Scaglioni; Matteo Meroni; Elmar Fritsche
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241

6.  Long-Term Outcomes of Lymph Node Transfer in Secondary Lymphedema and Its Correlation with Flap Characteristics.

Authors:  Dimitrios Dionyssiou; Alexandros Sarafis; Antonios Tsimponis; Asterios Kalaitzoglou; Georgios Arsos; Efterpi Demiri
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.